OHE - Homepage
WEBOffice of Health Economics (OHE) is a leading authority on global health economics. We work to improve health care through research, analysis, and education.
About OHE - OHE
WEBThe Office of Health Economics (OHE) is founded. When the Office of Health Economics (OHE) was founded in 1962, the health care world was a vastly different place. Formal approval of drugs before marketing was yet not required i n the UK and pharmacology was in its infancy. Drug therapy was just beginning to tackle major illnesses such as heart disease: the beta blocker propranolol was ...
Academy - OHE
WEBFree on-demand Masterclass. Unlock the potential of multi-indication therapies at your own pace with our comprehensive on-demand Masterclass. Dive into the intersection of science, payment models, and patient care. Discover how individual medicines benefit patients across various indications and learn strategies for addressing access challenges.
Adult vaccination programmes deliver socio-economic benefits up …
WEBAdult vaccination programmes deliver socio-economic benefits up to 19 times initial investment, according to new report. Our new report examines the promise of prevention in healthcare and provides six key recommendations that could usher in a new era of optimised prevention.
Education Hub - OHE
WEBA globally accessible health economic educational hub that fosters understanding and knowledge of health economics. OHE’s educational mission is to support, sustain, and enhance the discipline of health economics through increasing its accessibility, awareness, impact, reach, and relevance. Our diversity of content ensures that we cater for ...
The Cost of Drug Shortages - OHE
WEB6 days ago · Total costs using our base case assumptions reached $1.45 billion in the US and €63 million in the EU. The large difference is explained by the inclusion (for US) or not (for EU) of costs associated with price increases of the drug in shortage and its alternatives. This is because for the EU case, we assume that the cost of purchasing ...
Research and Publications - OHE
WEBIndividual, Health System, and Societal Impacts of Anti-seizure Medicine Use During Pregnancy. OHE's research and publications cover a wide range of topics from the fundamentals of health economics to the challenges in …
The Promise of Gene Therapies: Are We Ready? - OHE
WEBJan 4, 2021 · In a webinar held on 16 March 2021, Mary Harney, Annie Hubert and Simone Boselli joined OHE’s Adrian Towse to debate the issues surrounding the adoption of gene therapies. In this interactive report we highlight our 5 key takeaways from the debate with clips, quotes and highlights.
Real-World Evidence: Current Best Practice for Reimbursement
WEBReal-world evidence (RWE) can enable better-informed patient access decisions, but it is underutilised in reimbursement decisions. This report reviews and synthesises best practices for the generation and use of RWE drawn from highly cited academic papers and published by well-established Health Technology Assessment (HTA) bodies.
Grow and diversify funding for prevention to boost the nation’s …
WEBOct 12, 2023 · OHE’s report lays out a clear case for investing in health prevention to reduce NHS demand and boost the economy; Analysis shows that existing prevention efforts are failing due to lack of uptake, underfunding, and short-termism
Skip to content